Core D: Program Administration
Core D: Program Administration
批准号:
10231105
负责人:
MATTHEW L. MEYERSON
金额:
$12.66万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-05-11 至 2023-08-31
关键词:
Advisory CommitteesBudgetsCancer CenterCancer PatientClinicClinicalClinical TrialsCollaborationsCommunicationCommunitiesConsultationsDana-Farber Cancer InstituteDevelopmentDiagnosticEnsureEvaluationEvaluation ResearchEventFosteringFundingGenomicsGoalsGrantGroup MeetingsJointsLeadMalignant neoplasm of lungManuscriptsMedical OncologistMethodsModelingMonitorNon-Small-Cell Lung CarcinomaPatientsPerformancePreparationProtein KinasePublicationsResearchResearch Project GrantsResource SharingScientistSuggestionTestingTherapeuticTherapeutic AgentsTherapeutic Human ExperimentationTranslatingTranslationsUnited StatesValidationclinical applicationclinical translationexperienceinnovationmeetingsmembernew therapeutic targetnovel therapeuticsprogramssuccesssynergismtargeted cancer therapytargeted treatmenttherapeutic target
中文摘要
项目管理核心将通过提供管理和
英文摘要
The Program Administration Core will facilitate the overall goals of the Program by providing administrative and
fiscal support as well as scientific oversight, to ensure that the activities of the Program are consistent with its
ultimate goal i.e. the development of new targeted therapies for non-small cell lung cancer. This involves
coordination of all Programmatic activities, in particular promoting collaboration, cross-talk and sharing of
information and ideas between the various Projects and Cores. This includes the assessment and
implementation of changes in research trajectory, as required, to ensure research progress and alignment of
activities with the overall goals of the program. This will be accomplished via the following Specific Aims:
Specific Aim 1: Monitor projects and shared resource cores and evaluate overall research progress.
a) Coordinate regular meetings of a Program Executive Committee, including each of the Project Leaders and
Core Directors, to monitor the progress of each Project and Shared Resource Core.
b) Provide regular guidance to the Project Leaders and Core Directors, including critical evaluation of
research progress and direction.
c) Obtain advice from an Internal Advisory Committee of scientists within Dana-Farber Cancer Institute, and
monitor the integration of the committee’s suggestions into the performance of the Projects and Cores.
d) Hold meetings of an External Advisory Board of scientists with expertise in lung cancer targeted therapies.
Specific Aim 2: Foster collaboration and communication among the projects and shared resource cores.
a) Arrange bi-weekly group meetings of the Program to share research ideas, results, and methods.
b) Monitor and encourage the interactions between projects and cores.
Specific Aim 3: Provide fiscal oversight and support for the program.
a) Assist with grants management and disbursement of funds.
b) Analyze and adjust budgets to incorporate ongoing innovations and as the program evolves.
Specific Aim 4: Promote the clinical translation of diagnostic and therapeutic discoveries from the program.
a) Ensure that translatable discoveries are effectively communicated to the Dana-Farber/Harvard Cancer
Center Lung Cancer Program.
b) Organize a retreat to disseminate the research findings and prompt synergistic interactions.
c) Assist in manuscript submission and subsequent publication.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Lung Adenocarcinoma: From Genome Alterations to Therapeutic Discovery
-
批准号:10299281
-
项目类别:
-
资助金额:$106.8万
-
财政年份:2015
-
负责人:MATTHEW L. MEYERSON
-
依托单位:
How do genome alterations cause human lung cancer?
-
批准号:8955791
-
项目类别:
-
资助金额:$102.56万
-
财政年份:2015
-
负责人:MATTHEW L. MEYERSON
-
依托单位:
NKX2-1 Enhancer Amplification and Lineage Addiction in Lung Adenocarcinoma
-
批准号:10598959
-
项目类别:
-
资助金额:$9.41万
-
财政年份:2015
-
负责人:MATTHEW L. MEYERSON
-
依托单位:
Lung Adenocarcinoma: From Genome Alterations to Therapeutic Discovery
-
批准号:10455040
-
项目类别:
-
资助金额:$102.37万
-
财政年份:2015
-
负责人:MATTHEW L. MEYERSON
-
依托单位:
How do genome alterations cause human lung cancer?
-
批准号:9118129
-
项目类别:
-
资助金额:$102.75万
-
财政年份:2015
-
负责人:MATTHEW L. MEYERSON
-
依托单位:
Lung Adenocarcinoma: From Genome Alterations to Therapeutic Discovery
-
批准号:10683176
-
项目类别:
-
资助金额:$102.37万
-
财政年份:2015
-
负责人:MATTHEW L. MEYERSON
-
依托单位:
Protein Kinase Therapeutic Targets for Non-Small Cell Lung Carcinoma
-
批准号:8490596
-
项目类别:
-
资助金额:$150.64万
-
财政年份:2012
-
负责人:MATTHEW L. MEYERSON
-
依托单位:
Protein Kinase Therapeutic Targets for Non-Small Cell Lung Carcinoma
-
批准号:8660037
-
项目类别:
-
资助金额:$169.53万
-
财政年份:2012
-
负责人:MATTHEW L. MEYERSON
-
依托单位:
Protein Kinase Therapeutic Targets for Non-Small Cell Lung Carcinoma
-
批准号:8844212
-
项目类别:
-
资助金额:$174.77万
-
财政年份:2012
-
负责人:MATTHEW L. MEYERSON
-
依托单位:
Project 3: Targeting transcriptional mechanisms of therapeutic resistance in non-small cell lung cancer.
-
批准号:10231100
-
项目类别:
-
资助金额:$34.82万
-
财政年份:2012
-
负责人:MATTHEW L. MEYERSON
-
依托单位:
Protein Kinase Therapeutic Targets for Non-Small Cell Lung Carcinoma
-
批准号:9766077
-
项目类别:
-
资助金额:$184.71万
-
财政年份:2012
-
负责人:MATTHEW L. MEYERSON
-
依托单位:
Protein Kinase Therapeutic Targets for Non-Small Cell Lung Carcinoma
-
批准号:10231097
-
项目类别:
-
资助金额:$184.62万
-
财政年份:2012
-
负责人:MATTHEW L. MEYERSON
-
依托单位:
DDR2 kinase inhibition in squamous cell lung carcinomas
-
批准号:8237129
-
项目类别:
-
资助金额:$42.66万
-
财政年份:2012
-
负责人:MATTHEW L. MEYERSON
-
依托单位:
Administration
-
批准号:8237139
-
项目类别:
-
资助金额:$16.98万
-
财政年份:2012
-
负责人:MATTHEW L. MEYERSON
-
依托单位:
Protein Kinase Therapeutic Targets for Non-Small Cell Lung Carcinoma
-
批准号:8216244
-
项目类别:
-
资助金额:$188.44万
-
财政年份:2012
-
负责人:MATTHEW L. MEYERSON
-
依托单位:
Center for Cancer Genome Characterization
-
批准号:7911111
-
项目类别:
-
资助金额:$61.13万
-
财政年份:2009
-
负责人:MATTHEW L. MEYERSON
-
依托单位:
An infrastructure for cancer virus discovery from next-generation sequencing data
-
批准号:7856252
-
项目类别:
-
资助金额:$76.51万
-
财政年份:2009
-
负责人:MATTHEW L. MEYERSON
-
依托单位:
An infrastructure for cancer virus discovery from next-generation sequencing data
-
批准号:7941869
-
项目类别:
-
资助金额:$78.64万
-
财政年份:2009
-
负责人:MATTHEW L. MEYERSON
-
依托单位:
Inhibitor-sensitive and -resistant EGFR mutants from lung cancer and glioblastoma
-
批准号:7213358
-
项目类别:
-
资助金额:$32.57万
-
财政年份:2006
-
负责人:MATTHEW L. MEYERSON
-
依托单位:
Center for Cancer Genome Characterization
-
批准号:7233746
-
项目类别:
-
资助金额:$238.78万
-
财政年份:2006
-
负责人:MATTHEW L. MEYERSON
-
依托单位:
海外基金